Unicycive Therapeutics, Inc. (UNCY) Misses Q2 EPS by 143c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q2 EPS of ($1.50), $1.43 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• Dell Technologies (DELL) added to S&P 100 index
• S&P announces major changes in S&P 100, S&P 500, S&P 400